- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04982042
Post COVID-19 Pulmonary Rehabilitation Program (COVID19REHAB)
Outpatient and Home Pulmonary Rehabilitation Program for Post COVID-19 Patients
Coronavirus-2019 disease (COVID-19) is a highly infectious respiratory disease that causes respiratory, physical and psychological dysfunction in patients.
With the increased understanding of the severity of COVID-19 and clinical evidence in accordance with the opinions of first-line clinical experts involved in the treatment of this epidemic, the investigators believe that the participation of patients with sequelae of COVID-19 in a Pulmonary Rehabilitation Program would be of utmost importance.
According to recent scientific recommendations for patients with sequelae of COVID-19, respiratory rehabilitation would alleviate symptoms of dyspnea, anxiety and depression and, eventually, improve physical functions and quality of life.
Therefore, it is essential to anticipate early rehabilitation after the acute phase of ARDS, in order to limit the severity of the effects of the ICU and promote rapid functional recovery. Physiotherapy will play a role in providing exercise, mobilization and rehabilitation interventions for survivors of critical illnesses associated with COVID-19, in order to enable a functional social return.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The investigatores propose a clinical, prospective and consecutive study composed of participants with pulmonary sequelae of COVID-19 and pulmonary diseases such as COPD, Asthma, Bronchitis, Emphysema, Bronchiectasis and pulmonary fibrosis. Initially, all patients will undergo a physical assessment, pulmonary function tests and nutritional assessment, in addition to applying the modified dyspnea scale of the MMRC (Modified Medical Research Council) and the 6-minute walk test (6MWT), according to the standards recommended by the American Thoracic Society (ATS).
The proposed Outpatient and Home Pulmonary Rehabilitation Program is based on the Guidelines recommended by the Brazilian Society of Pulmonology (SBPT) and by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), with a minimum duration of 12 weeks, frequency of 3 weekly sessions, accompanied by health professionals in this field.
Patients who seek care at municipal and state health services in the city of Anápolis, (Goiás) will be recruited. Patients with clinically stabilized COVID - 19 sequelae will be considered eligible, and who agree to participate in the study, signing the Informed Consent .
The outpatient PRP consisted of a combination of aerobic and strengthening exercises, lasting 12 weeks, frequency 3 times a week. Each session will consist of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises. The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Luis LV Oliveira, PhD
- Número de teléfono: 0055 62 999052309
- Correo electrónico: oliveira.lvf@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Luis VF Oliveira, PhD
- Número de teléfono: 0055 62 999052309
- Correo electrónico: luis.oliveira@unievangelica.edu.br
Ubicaciones de estudio
-
-
GO
-
Anápolis, GO, Brasil, 75083-515
- Reclutamiento
- Centro Universitário de Anápolis - UniEVANGÉLICA
-
Contacto:
- Luis VF Oliveira, PhD
- Número de teléfono: 6717 +55 62 33106600
- Correo electrónico: oliveira.lvf@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients with a diagnosis of pulmonary sequelae post COVID-19
- Patients clinically stabilized
- Who agreed to participate in the clinical study, signing the informed consent form, will be considered eligible.
Exclusion Criteria:
- Hospitalized patients
- Patients who present clinical instability
- Patients who do not commit to adhering to the Pulmonary Rehabilitation Program
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Post COVID-19 Outpatient Pulmonary Rehabilitation Program
The outpatient Pulmonary Rehabilitation Program will be carried out at the Pulmonary Rehabilitation Laboratory, consisting of a combination of aerobic and strengthening exercises, lasting 12 weeks, with a frequency of 3 times a week, always in the morning.
Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises.
The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
|
The Pulmonary Rehabilitation Program consists of a combination of aerobic and strengthening exercises, lasting 12 weeks, with a frequency of 3 times a week, always in the morning.
Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises.
The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
|
|
Comparador activo: Post COVID-19 Home Pulmonary Rehabilitation Program
The Home Pulmonary Rehabilitation Program will be carried out at the patients' homes, consisting of the same combination of aerobic and strengthening exercises, lasting 12 weeks, 3 times a week, always in the morning.
Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises.
The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
Patients will be monitored weekly via whatsapp.
|
The Pulmonary Rehabilitation Program consists of a combination of aerobic and strengthening exercises, lasting 12 weeks, with a frequency of 3 times a week, always in the morning.
Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises.
The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Functional status after Pulmonary Rehabilitation Program (COVID-19REHAB)
Periodo de tiempo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on levels of functional status assessed with the Medical Research Council (MRC) Scale in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Exercise capacity after Pulmonary Rehabilitation Program (COVID-19REHAB)
Periodo de tiempo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on exercise capacity assessed with the six minutes Walk Test ( 6MWT) in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Forced Vital Capacity after Pulmonary Rehabilitation Program (COVID-19REHAB)
Periodo de tiempo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the forced vital capacity (FVC) measured by spirometry in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Forced Expiratory Volume in first second after Pulmonary Rehabilitation Program (COVID-19REHAB)
Periodo de tiempo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the forced expiratory volume in first second (FEV1) measured by spirometry in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Inspiratory muscle strength after Pulmonary Rehabilitation Program (COVID-19REHAB)
Periodo de tiempo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the inspiratory muscles strength measured by vacuometry in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Peripheral muscle strength after Pulmonary Rehabilitation Program (COVID-19REHAB)
Periodo de tiempo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the peripheral muscle strength measured by Hand Grip Dynamometer in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Levels of anxiety and depression after Pulmonary Rehabilitation Program (COVID-19REHAB)
Periodo de tiempo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the Anxiety and depression levels measured by the Hospital Anxiety and Depression scale in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Quality of Life after Pulmonary Rehabilitation Program (COVID-19REHAB)
Periodo de tiempo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the Quality of Life levels measured by Medical Outcomes Study/SF-36 Questionnaire in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Health costs after COVID - 19.
Periodo de tiempo: 36 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on healthcare costs verified through the financial expenses of patients with pulmonary sequelae resulting from COVID-19.
|
36 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Luis VF OLiveira, PhD, Evangelical University of Goiás - UNIEVANGELICA
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Desordenes mentales
- Procesos Patológicos
- Enfermedades del Sistema Nervioso
- Infecciones por coronavirus
- Infecciones por coronaviridae
- Infecciones por Nidovirales
- Infecciones por virus de ARN
- Enfermedades virales
- Infecciones
- Enfermedades de las vías respiratorias
- Trastornos de la respiración
- Neumonía Viral
- Neumonía
- Manifestaciones neurológicas
- Enfermedades musculoesqueléticas
- Enfermedades Musculares
- Manifestaciones Neuromusculares
- COVID-19
- Enfermedades pulmonares
- Debilidad muscular
- Insuficiencia respiratoria
- Desórdenes de ansiedad
- Infecciones del Tracto Respiratorio
Otros números de identificación del estudio
- COVID-19 PULMONARY REHAB
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Marco de tiempo para compartir IPD
Criterios de acceso compartido de IPD
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- CIF
- RSC
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .